Abstract
In eight patients with rheumatoid arthritis receiving racemic hydroxychloroquine, blood and urine concentrations of the enantiomers of hydroxychloroquine and its major metabolites were measured each month over the first 6 months of therapy. Plasma concentrations of hydroxychloroquine enantiomers were measured in five of these patients. In all patients, the blood concentration of (R)-hydroxychloroquine exceeded that of the (S)-enantiomer, the mean (R)/(S) ratio being 2.2 (range 1.6-2.9). A similar excess of (R)-hydroxychloroquine was found in the plasma, the mean (R)/(S) ratio being 1.6 (range 1.2-1.9). The mean enantiomer blood concentration ratio (R)/(S) for the metabolite desethylhydroxychloroquine was 0.45 (range 0.34-0.58) and for desethylchloroquine it was 0.56 (range 0.35-0.86) suggesting stereoselective metabolism of hydroxychloroquine. (S)-hydroxychloroquine had a mean (+/- s.d.) renal clearance from blood of 41 +/- 11 ml min-1, approximately twice that of (R)-hydroxychloroquine. The predicted unbound renal clearance was also higher for (S)-hydroxychloroquine. The clinical implications of enantioselective disposition of hydroxychloroquine are currently not known.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Fink E., Minet G., Nickel P. Chloroquin-Enantiomere. Wirkung gegen Nagetiermalaria (P. vinckei) und Bindung an DNS. Arzneimittelforschung. 1979;29(1):163–164. [PubMed] [Google Scholar]
- Haberkorn A., Kraft H. P., Blaschke G. Antimalarial activity of the optical isomers of chloroquine diphosphate. Tropenmed Parasitol. 1979 Sep;30(3):308–312. [PubMed] [Google Scholar]
- McLachlan A. J., Tett S. E., Cutler D. J. High-performance liquid chromatographic separation of the enantiomers of hydroxychloroquine and its major metabolites in biological fluids using an alpha 1-acid glycoprotein stationary phase. J Chromatogr. 1991 Sep 18;570(1):119–127. doi: 10.1016/0378-4347(91)80206-r. [DOI] [PubMed] [Google Scholar]
- Ofori-Adjei D., Ericsson O., Lindström B., Hermansson J., Adjepon-Yamoah K., Sjöqvist F. Enantioselective analysis of chloroquine and desethylchloroquine after oral administration of racemic chloroquine. Ther Drug Monit. 1986;8(4):457–461. doi: 10.1097/00007691-198612000-00014. [DOI] [PubMed] [Google Scholar]
- Tett S. E., Cutler D. J., Brown K. F. High-performance liquid chromatographic assay for hydroxychloroquine and metabolites in blood and plasma, using a stationary phase of poly(styrene divinylbenzene) and a mobile phase at pH 11, with fluorimetric detection. J Chromatogr. 1985 Nov 8;344:241–248. doi: 10.1016/s0378-4347(00)82024-1. [DOI] [PubMed] [Google Scholar]
- Tett S. E., Cutler D. J., Day R. O., Brown K. F. A dose-ranging study of the pharmacokinetics of hydroxy-chloroquine following intravenous administration to healthy volunteers. Br J Clin Pharmacol. 1988 Sep;26(3):303–313. doi: 10.1111/j.1365-2125.1988.tb05281.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tett S. E., Cutler D. J., Day R. O., Brown K. F. Bioavailability of hydroxychloroquine tablets in healthy volunteers. Br J Clin Pharmacol. 1989 Jun;27(6):771–779. doi: 10.1111/j.1365-2125.1989.tb03439.x. [DOI] [PMC free article] [PubMed] [Google Scholar]